17 results
6-K
EX-99.1
IPHA
Innate Pharma
24 Mar 22
Innate Pharma S.a. 6-K
6:00am
in the United States in October 2019. It also includes increases related to staff training (catch-up observed in 2021 following the impact of COVID
6-K
EX-99.1
i2ixxya1qb8
11 Aug 20
Innate Pharma Obtains €6.8M in Public Funding for Its COVID-19 Research And Development Activities
3:13pm
20-F
gerfgtr401p0q81icju
24 Apr 20
Annual report (foreign)
10:43am
424B4
zi237g
18 Oct 19
Prospectus supplement with pricing info
4:08pm
F-1/A
fvlwiz pbz
4 Oct 19
Registration statement (foreign) (amended)
4:56pm
F-1
dq6df78aa4ee94liewb
20 Sep 19
Registration statement (foreign)
4:08pm
F-1
EX-10.2
f9810art
20 Sep 19
Registration statement (foreign)
4:08pm
F-1
EX-10.1
nevdsuqk
20 Sep 19
Registration statement (foreign)
4:08pm
DRS/A
EX-10.1
cpkhz308ol sy
30 Aug 19
Draft registration statement (amended)
12:00am
DRS/A
EX-10.2
fl6axq29ffgntgtd
30 Aug 19
Draft registration statement (amended)
12:00am
DRS/A
nbeft0w70 gop1mtj8
30 Aug 19
Draft registration statement (amended)
12:00am
DRS/A
objltg5tfozw6
19 Jul 19
Draft registration statement (amended)
12:00am
DRS
td5se9atqup79l
10 Jun 19
Draft registration statement
12:00am
- Prev
- 1
- Next